GDTC logo

CytoMed Therapeutics Limited (GDTC) Operating Profit

Annual Operating Profit

-$2.86 M
-$1.51 M-112.37%

31 December 2023

GDTC Operating Profit Chart

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

GDTC Operating Profit Performance

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year-112.4%--
3 y3 years-214.0%--
5 y5 years---

GDTC Operating Profit High & Low

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3 years-214.0%at low
5 y5 years-214.0%at low
alltimeall time-214.0%at low

CytoMed Therapeutics Limited Operating Profit History

DateAnnualQuarterlyTTM
Dec 2023
-$2.86 M(+112.4%)
-
-
Dec 2022
-$1.35 M(+4.8%)
-
-
DateAnnualQuarterlyTTM
Dec 2021
-$1.29 M(+41.1%)
-
-
Dec 2020
-$911.10 K
-
-

FAQ

  • What is CytoMed Therapeutics Limited annual operaing income?
  • What is the all time high annual operating profit for CytoMed Therapeutics Limited?
  • What is CytoMed Therapeutics Limited annual operating profit year-on-year change?

What is CytoMed Therapeutics Limited annual operaing income?

The current annual operating profit of GDTC is -$2.86 M

What is the all time high annual operating profit for CytoMed Therapeutics Limited?

CytoMed Therapeutics Limited all-time high annual operaing income is -$911.10 K

What is CytoMed Therapeutics Limited annual operating profit year-on-year change?

Over the past year, GDTC annual operaing income has changed by -$1.51 M (-112.37%)